Post-Market Surveillance
Establish a proactive post-market surveillance system that meets EU MDR Articles 83-86 requirements. Aggregate data from complaints, vigilance reports, literature, and registries to generate PMS plans and reports that demonstrate ongoing product safety monitoring.
Part of Clinical & Post-Market
Regulatory Context
Key Capabilities
What you get with the Post-Market Surveillance module.
See Clinical & Post-Market in action
Watch how MoniDoseQMS handles clinical & post-market workflows end-to-end.
Getting Started
Build your own QMS
Register an account and assemble your quality system from only the modules you need — set up in minutes, with no implementation fee.
Getting Started
Platform tour
A guided tour of MoniDoseQMS after you log in — your profile, the everyday tools (notifications, recycle bin, tasks, events, regulatory news), and the dashboard.
Why It Matters
How Post-Market Surveillance helps your organisation.
How It Connects
Post-Market Surveillancedoesn't work in isolation. It connects seamlessly with other modules in MoniDoseQMS for full traceability across your quality system.
Ready to see Post-Market Surveillance in action?
Book a 30-minute demo tailored to your regulatory needs. Our team will walk you through how Post-Market Surveillance works within your specific compliance context.
More in Clinical & Post-Market
Explore other modules in the Clinical & Post-Market category.
Benefit-Risk Analysis
Systematically evaluate the clinical benefits of your products against their residual risks to support regulatory submissions and market access decisions. Document your benefit-risk determination in a structured format that meets EU MDR and global regulatory expectations.
Clinical Investigations
Plan and manage clinical investigations for medical devices with structured study management covering protocol development, site management, and regulatory submissions. Ensure your clinical studies meet ISO 14155 and EU MDR requirements from start to finish.
Clinical Evaluations
Conduct and document clinical evaluations as required by EU MDR and MEDDEV 2.7/1 Rev 4. Systematically assess clinical data from literature, clinical investigations, and post-market surveillance to demonstrate safety and performance of your devices.
Literature Reviews
Conduct systematic literature reviews to support clinical evaluations, risk management, and post-market surveillance activities. Document your search strategies, screening criteria, and analysis results in a structured format that meets regulatory expectations.
PMCF Plans
Develop Post-Market Clinical Follow-up plans that define your strategy for proactively collecting clinical data after market placement. Meet EU MDR Annex XIV Part B requirements with structured PMCF plans that identify methods, milestones, and evaluation criteria.
PMCF Evaluation Reports
Document the results of Post-Market Clinical Follow-up activities with structured evaluation reports. Analyze PMCF data to confirm ongoing safety and performance and identify any emerging clinical risks that require action.